 |
05-May-08: Insilicos Awarded Grant for Life Science Computing 03-Apr-08: Insilicos Wins NIH Grant for Manufacturing 14-Jan-08: Insilicos Heart Disease Project Wins Research Funding 30-Aug-07: Insilicos Awarded $1 Million Grant for Biotech Services 30-Apr-07: Insilicos Names Heinecke to Chief Medical Advisor Post 22-Sep-06: Insilicos and GeneBio Sign Global Distribution Agreement 29-May-06: Insilicos Announces Breakthrough Proteomics Software Platform 28-Mar-06: Insilicos Announces 1000th Licensed User of InsilicosViewer 13-Mar-06: Insilicos Awarded Grant to Study Heart Disease 14-Feb-06: Insilicos CEO Erik Nilsson Interviewed 06-Feb-06: Insilicos Awarded Grant to Commercialize Proteomics Research 14-Sep-05: Insilicos announces support for biotech data format 31-Aug-05: Insilicos Announces Web Support for Biotech Tools 08-Jul-05: Insilicos appoints Teresa Skarr as Director of Regulatory Affairs 04-Jun-05: Insilicos Announces 500th Licensed User of InsilicosViewer 27-Apr-05: Insilicos Presents at Invest Northwest 31-Mar-05: Insilicos releases new version of viewer 23-Feb-05: Insilicos Awarded Proteomics Grant 14-Dec-04: Ruedi Aebersold joins Insilicos Advisory Board 01-Sep-04: InsilicosViewer in the News 15-Apr-04: Insilicos Wins NIH Grant 13-Oct-03: Insilicos Releases Beta 26-Jun-03: Insilicos Wins Grant 30-Sep-02: Insilicos Platform Project Announced
| |
Seattle, 26 June 2003:
The National Science Foundation has awarded Insilicos an STTR grant to study the
application of multidimensional separations of metabolomics to analysis of microbial cell metabolism.
Insilicos president Erik Nilsson is Principal Investigator (PI) on the grant.
Professor Robert Synovec of the University of Washington is co-PI.
Insilicos' research collaborators for this grant are the
Synovec Lab
and the
Lidstrom Lab
at the University of Washington.
"We're glad the NSF saw merit in our approach," said Nilsson.
"This is a big vote of confidence."
"In this research, we hope to establish relationships between measurements of the
metabolome, the proteome, and the genome," said Insilicos Chief Scientist Bryan Prazen.
"We are exploring new analytical techniques, with applications to research, medicine, and industry"Insilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.
|
|
